USIC -BNAT: Intra Hospital Mortality Risk Factors in Patients Admitted to Cardiac Intensive Care Units in 2017 in France

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT03835169
Collaborator
(none)
200,000
1
23.2
8622.5

Study Details

Study Description

Brief Summary

Retrospective, observational cohort study.

Objectives:

To identify intra hospital mortality risk factors in patients admitted admitted to cardiac intensive care units (CICU). The clinical main endpoint will be the observed percentage of deaths that occured during the year 2017 in french CICU.

To identify the length of stay key determiners of patients admitted in french CICU.

The study will use data from one of the french nationwide healthcare systems database (SNDS) : the national hospital discharge database (PMSI) to be precise.

Study Design

Study Type:
Observational
Actual Enrollment :
200000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Intra Hospital Mortality Risk Factors in Patients Admitted to Cardiac Intensive Care Units in 2017 in France: A Nationwide Retrospective Observational Cohort Study Using Data From the French Hospital Discharge Database
Actual Study Start Date :
Jan 24, 2019
Actual Primary Completion Date :
Dec 1, 2020
Actual Study Completion Date :
Dec 30, 2020

Outcome Measures

Primary Outcome Measures

  1. Mortality rate [1 day]

    Observed percentage of deaths that occured during the year 2017 in french CICU

Secondary Outcome Measures

  1. Length of stay at a CICU [1 year]

    Length of stay at a CICU

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria:
  • Being admitted at least one time in a french CICU in 2017

  • Being covered by the mandatory french national health insurance plan in 2017 without discontinuity

Exclusion criteria:
  • Being older than 18 years of age

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uhmontpellier Montpellier France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Principal Investigator: François Roubille, MD, PhD, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT03835169
Other Study ID Numbers:
  • RECHMPL18_0429
First Posted:
Feb 8, 2019
Last Update Posted:
Aug 11, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 11, 2022